{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T18:42:22Z","timestamp":1790707342936,"version":"4.1.0"},"reference-count":56,"publisher":"Elsevier BV","issue":"6-7","license":[{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Revue Neurologique"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1016\/j.neurol.2012.01.587","type":"journal-article","created":{"date-parts":[[2012,5,28]],"date-time":"2012-05-28T13:16:28Z","timestamp":1338210988000},"page":"512-521","source":"Crossref","is-referenced-by-count":5,"title":["Traitement de l\u2019isch\u00e9mie c\u00e9r\u00e9brale art\u00e9rielle et veineuse. Recommandations formalis\u00e9es d\u2019experts\u00a0: Prise en charge de l\u2019AVC par le r\u00e9animateur"],"prefix":"10.1016","volume":"168","author":[{"given":"D.","family":"Calvet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Bracard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.-L.","family":"Mas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurol.2012.01.587_bib0005","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1161\/01.STR.0000157668.39374.56","article-title":"Emergency administration of abciximab for treatment of patients with acute ischemic stroke: results of a randomized phase 2\u00a0trial","volume":"36","author":"AbESTT (Abciximab Emergent Stroke Treatment Trial Investigators)","year":"2005","journal-title":"Stroke"},{"key":"10.1016\/j.neurol.2012.01.587_bib0010","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1161\/STROKEAHA.107.181486","volume":"38","author":"Adams","year":"2007","journal-title":"Stroke"},{"key":"10.1016\/j.neurol.2012.01.587_bib0015","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1161\/STROKEAHA.106.476648","article-title":"Emergency administration of abciximab for treatment of patients with acute ischemic stroke: results of an international phase III trial: Abciximab in Emergency Treatment of Stroke Trial (AbESTT-II)","volume":"39","author":"Adams","year":"2008","journal-title":"Stroke"},{"key":"10.1016\/j.neurol.2012.01.587_bib0020","series-title":"100mg. Avis de la comission de la transparence du 2\u00a0juillet 2003","article-title":"ACTILYSE, poudre et solvant pour solution injectable, flacons de 10mg, 20mg, 50mg","author":"Agence fran\u00e7aise de s\u00e9curit\u00e9 sanitaire des produits de sant\u00e9.","year":"2003"},{"key":"10.1016\/j.neurol.2012.01.587_bib0025","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1001\/archneurol.2010.210","article-title":"Association of admission blood glucose and outcome in patients treated with intravenous thrombolysis: results from the Safe Implementation of Treatments in Stroke International Stroke Thrombolysis Register (SITS-ISTR)","volume":"67","author":"Ahmed","year":"2010","journal-title":"Arch Neurol"},{"key":"10.1016\/j.neurol.2012.01.587_bib0030","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1056\/NEJMoa041175","article-title":"Ultrasound-enhanced systemic thrombolysis for acute ischemic stroke","volume":"351","author":"Alexandrov","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.neurol.2012.01.587_bib0035","doi-asserted-by":"crossref","first-page":"546S","DOI":"10.1378\/chest.08-0678","article-title":"Evidence-based clinical practice guidelines (8th edition). Antithrombotic therapy in atrial fibrillation","volume":"133","author":"American College of chest physicians","year":"2008","journal-title":"Chest"},{"key":"10.1016\/j.neurol.2012.01.587_bib0040","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/S0140-6736(01)05837-8","article-title":"Tinzaparin in acute ischaemic stroke (TAIST): a randomised aspirin-controlled trial","volume":"358","author":"Bath","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.neurol.2012.01.587_bib0045","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/S0140-6736(00)02085-7","article-title":"Low molecular-weight heparin versus aspirin in patients with acute ischaemic stroke and atrial fibrillation: a double-blind randomised study. HAEST Study Group. Heparin in acute embolic stroke trial","volume":"355","author":"Berge","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.neurol.2012.01.587_bib0050","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.3174\/ajnr.A1110","article-title":"The Penumbra system: a mechanical device for the treatment of acute stroke due to thromboembolism","volume":"29","author":"Bose","year":"2008","journal-title":"AJNR Am J Neuroradiol"},{"key":"10.1016\/j.neurol.2012.01.587_bib0055","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.1161\/01.STR.0000185730.50480.e7","article-title":"Intravenous heparin started within the first 3hours after onset of symptoms as a treatment for acute nonlacunar hemispheric cerebral infarctions","volume":"36","author":"Camerlingo","year":"2005","journal-title":"Stroke"},{"key":"10.1016\/j.neurol.2012.01.587_bib0060","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1016\/S0140-6736(97)04010-5","article-title":"Randomised placebo-controlled trial of early aspirin use in 20,000\u00a0patients with acute ischaemic stroke","volume":"349","author":"CAST (Chinese Acute Stroke Trial) Collaborative Group","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.neurol.2012.01.587_bib0065","doi-asserted-by":"crossref","first-page":"3052","DOI":"10.1161\/01.STR.0000248952.59078.7a","article-title":"Immediate anticoagulation for acute stroke in atrial fibrillation: yes","volume":"37","author":"Chamorro","year":"2006","journal-title":"Stroke"},{"key":"10.1016\/j.neurol.2012.01.587_bib0070","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1159\/000086100","article-title":"The rapid anticoagulation prevents ischemic damage study in acute stroke\u00a0\u2013\u00a0final results from the writing committee","volume":"19","author":"Chamorro","year":"2005","journal-title":"Cerebrovasc Dis"},{"key":"10.1016\/j.neurol.2012.01.587_bib0075","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1161\/01.STR.30.3.484","article-title":"Randomized, placebo-controlled trial of anticoagulant treatment with low-molecular-weight heparin for cerebral sinus thrombosis","volume":"30","author":"de Bruijn","year":"1999","journal-title":"Stroke"},{"key":"10.1016\/j.neurol.2012.01.587_bib0080","doi-asserted-by":"crossref","first-page":"2945","DOI":"10.1161\/STROKEAHA.109.192535","article-title":"Expansion of the time window for treatment of acute ischemic stroke with intravenous tissue plasminogen activator: a science advisory from the American Heart Association\/American Stroke Association","volume":"40","author":"Del Zoppo","year":"2009","journal-title":"Stroke"},{"key":"10.1016\/j.neurol.2012.01.587_bib0085","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1161\/01.STR.0000181116.15426.58","article-title":"Importance of early ischemic computed tomography changes using ASPECTS in NINDS Stroke Study","volume":"36","author":"Demchuk","year":"2005","journal-title":"Stroke"},{"key":"10.1016\/j.neurol.2012.01.587_bib0090","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1136\/jnnp.2007.133371","article-title":"Intracerebral haemorrhage after thrombolysis for acute ischaemic stroke: an update","volume":"79","author":"Derex","year":"2008","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.neurol.2012.01.587_bib0095","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1161\/01.STR.32.1.22","article-title":"Treatment of acute ischemic stroke with the low-molecular-weight heparin certoparin: results of the TOPAS trial","volume":"32","author":"Diener","year":"2001","journal-title":"Stroke"},{"key":"10.1016\/j.neurol.2012.01.587_bib0100","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/S0150-9861(05)83018-4","article-title":"Comparison of intravenous and intra-arterial urokinase thrombolysis for acute ischaemic stroke","volume":"32","author":"Ducrocq","year":"2005","journal-title":"J Neuroradiol"},{"key":"10.1016\/j.neurol.2012.01.587_bib0105","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1111\/j.1468-1331.2006.01398.x","article-title":"EFNS guideline on the treatment of cerebral venous and sinus thrombosis","volume":"13","author":"Einhaupl","year":"2006","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.neurol.2012.01.587_bib0110","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/0140-6736(91)90607-Q","article-title":"Heparin treatment in sinus venous thrombosis","volume":"338","author":"Einhaupl","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/j.neurol.2012.01.587_bib0115","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1161\/01.STR.31.11.2552","article-title":"Combined intravenous and intra-arterial recombinant tissue plasminogen activator in acute ischemic stroke","volume":"31","author":"Ernst","year":"2000","journal-title":"Stroke"},{"key":"10.1016\/j.neurol.2012.01.587_bib0120","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1159\/000131083","article-title":"Guidelines for management of ischaemic stroke and transient ischaemic attack 2008","volume":"25","author":"ESO Executive Committee and the ESO Writing Committee","year":"2008","journal-title":"Cerebrovasc Dis"},{"key":"10.1016\/j.neurol.2012.01.587_bib0125","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1161\/01.STR.0000260187.33864.a7","article-title":"Mechanical thrombectomy of intracranial internal carotid occlusion: pooled results of the MERCI and Multi MERCI Part I trials","volume":"38","author":"Flint","year":"2007","journal-title":"Stroke"},{"key":"10.1016\/j.neurol.2012.01.587_bib0130","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1001\/jama.282.21.2003","article-title":"Intra-arterial pro-urokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in acute cerebral thromboembolism","volume":"282","author":"Furlan","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.neurol.2012.01.587_bib0135","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1161\/01.STR.0000217403.66996.6d","article-title":"Dose escalation of desmoteplase for acute ischemic stroke (DEDAS): evidence of safety and efficacy 3\u00a0to 9hours after stroke onset","volume":"37","author":"Furlan","year":"2006","journal-title":"Stroke"},{"key":"10.1016\/j.neurol.2012.01.587_bib0140","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1161\/01.STR.0000149938.08731.2c","article-title":"The Desmoteplase in Acute Ischemic Stroke Trial (DIAS): a phase II MRI-based 9-hour window acute stroke thrombolysis trial with intravenous desmoteplase","volume":"36","author":"Hacke","year":"2005","journal-title":"Stroke"},{"key":"10.1016\/j.neurol.2012.01.587_bib0145","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/S0140-6736(04)15692-4","article-title":"Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials","volume":"363","author":"Hacke","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.neurol.2012.01.587_bib0150","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1056\/NEJMoa0804656","article-title":"Thrombolysis with alteplase 3\u00a0to 4.5hours after acute ischemic stroke","volume":"359","author":"Hacke","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.neurol.2012.01.587_bib0155","unstructured":"HAS Haute autorit\u00e9 de Sant\u00e9. Recommandations de bonne pratique. Accident vasculaire c\u00e9r\u00e9bral: Prise en charge pr\u00e9coce (Alerte, phase pr\u00e9hospitli\u00e8re, phase hospitali\u00e8re initiale, indications de la thrombolyse). 2009."},{"key":"10.1016\/j.neurol.2012.01.587_bib0160","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1161\/STROKEAHA.107.483131","article-title":"The Interventional Management of Stroke","volume":"38","author":"IMS Study II","year":"2007","journal-title":"Stroke"},{"key":"10.1016\/j.neurol.2012.01.587_bib0165","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1016\/S0140-6736(97)04011-7","article-title":"A randomised trial of aspirin, subcutaneous heparin, both, or neither among 19435\u00a0patients with acute ischaemic stroke","volume":"349","author":"IST-The International Stroke Trial Collaborative Group","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.neurol.2012.01.587_bib0170","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1056\/NEJM199512143332402","article-title":"Low-molecular-weight heparin for the treatment of acute ischemic stroke","volume":"333","author":"Kay","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.neurol.2012.01.587_bib0175","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1111\/j.1747-4949.2008.00151.x","article-title":"Methodology of the Interventional Management of Stroke III Trial","volume":"3","author":"Khatri","year":"2008","journal-title":"Int J Stroke"},{"key":"10.1016\/j.neurol.2012.01.587_bib0180","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1161\/STROKEAHA.106.480475","article-title":"Risk factors of symptomatic intracerebral hemorrhage after tPA therapy for acute stroke","volume":"38","author":"Lansberg","year":"2007","journal-title":"Stroke"},{"key":"10.1016\/j.neurol.2012.01.587_bib0185","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1056\/NEJM199607183350301","article-title":"The Multicenter Acute Stroke Trial\u00a0\u2013\u00a0Europe Study Goroup Thrombolytic therapy with streptokinase in acute ischemic stroke","volume":"335","author":"MAST- E","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.neurol.2012.01.587_bib0190","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1016\/S0140-6736(95)92049-8","article-title":"Randomised controlled trial of streptokinase, aspirin, and combination of both in treatment of acute ischaemic stroke","volume":"346","author":"MAST-I Multicentre Acute Stroke Trial-Italy","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.neurol.2012.01.587_bib0195","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1161\/STROKEAHA.107.492348","article-title":"Comparison of intra-arterial and intravenous thrombolysis for ischemic stroke with hyperdense middle cerebral artery sign","volume":"39","author":"Mattle","year":"2008","journal-title":"Stroke"},{"key":"10.1016\/j.neurol.2012.01.587_bib0200","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1111\/j.1747-4949.2008.00190.x","article-title":"Design of the economic evaluation for the Interventional Management of Stroke (III) trial","volume":"3","author":"Mauldin","year":"2008","journal-title":"Int J Stroke"},{"key":"10.1016\/j.neurol.2012.01.587_bib0205","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/S1474-4422(09)70182-6","article-title":"Comparison of intravenous alteplase with a combined intravenous-endovascular approach in patients with stroke and confirmed arterial occlusion (RECANALISE study): a prospective cohort study","volume":"8","author":"Mazighi","year":"2009","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.neurol.2012.01.587_bib0210","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1161\/01.STR.0000199064.94588.39","article-title":"Microbubble administration accelerates clot lysis during continuous 2-MHz ultrasound monitoring in stroke patients treated with intravenous tissue plasminogen activator","volume":"37","author":"Molina","year":"2006","journal-title":"Stroke"},{"key":"10.1016\/j.neurol.2012.01.587_bib0215","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1056\/NEJM199512143332401","article-title":"Tissue plasminogen activator for acute ischemic stroke","volume":"333","author":"NINDS The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.neurol.2012.01.587_bib0220","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1161\/STROKEAHA.107.482554","article-title":"Outcome of stroke with mild or rapidly improving symptoms","volume":"38","author":"Nedeltchev","year":"2007","journal-title":"Stroke"},{"key":"10.1016\/j.neurol.2012.01.587_bib0225","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1161\/01.STR.0000254600.92975.1f","article-title":"Efficacy and safety of anticoagulant treatment in acute cardioembolic stroke: a meta-analysis of randomized controlled trials","volume":"38","author":"Paciaroni","year":"2007","journal-title":"Stroke"},{"key":"10.1016\/j.neurol.2012.01.587_bib0230","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1161\/01.STR.0000258112.14918.24","article-title":"The impact of recanalization on ischemic stroke outcome: a meta-analysis","volume":"38","author":"Rha","year":"2007","journal-title":"Stroke"},{"key":"10.1016\/j.neurol.2012.01.587_bib0235","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1136\/jnnp.2006.105890","article-title":"Thrombolytic therapy for acute ischaemic stroke in octogenarians: selection by magnetic resonance imaging improves safety but does not improve outcome","volume":"78","author":"Ringleb","year":"2007","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.neurol.2012.01.587_bib0240","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1161\/01.STR.0000199147.30016.74","volume":"37","author":"Sacco","year":"2006","journal-title":"Stroke"},{"key":"10.1016\/j.neurol.2012.01.587_bib0245","doi-asserted-by":"crossref","first-page":"3054","DOI":"10.1161\/01.STR.0000248924.00226.77","article-title":"Immediate anticoagulation for acute stroke in atrial fibrillation: no","volume":"37","author":"Sandercock","year":"2006","journal-title":"Stroke"},{"key":"10.1016\/j.neurol.2012.01.587_bib0250","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1161\/STROKEAHA.107.497115","article-title":"Mechanical thrombectomy for acute ischemic stroke: final results of the Multi MERCI trial","volume":"39","author":"Smith","year":"2008","journal-title":"Stroke"},{"key":"10.1016\/j.neurol.2012.01.587_bib0255","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1161\/01.STR.0000171066.25248.1d","article-title":"Safety and efficacy of mechanical embolectomy in acute ischemic stroke: results of the MERCI trial","volume":"36","author":"Smith","year":"2005","journal-title":"Stroke"},{"key":"10.1016\/j.neurol.2012.01.587_bib0265","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/S0140-6736(08)61339-2","article-title":"Thrombolysis with alteplase 3-4.5h after acute ischaemic stroke (SITS-ISTR): an observational study","volume":"372","author":"Wahlgren","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.neurol.2012.01.587_bib0270","doi-asserted-by":"crossref","first-page":"3316","DOI":"10.1161\/STROKEAHA.107.510768","article-title":"Multivariable analysis of outcome predictors and adjustment of main outcome results to baseline data profile in randomized controlled trials: Safe Implementation of Thrombolysis in Stroke-MOnitoring STudy (SITS-MOST)","volume":"39","author":"Wahlgren","year":"2008","journal-title":"Stroke"},{"key":"10.1016\/j.neurol.2012.01.587_bib0275","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD000213","article-title":"Thrombolysis for acute ischaemic stroke","volume":"CD000213","author":"Wardlaw","year":"2003","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.neurol.2012.01.587_bib0280","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S1474-4422(07)70079-0","article-title":"Low-molecular-weight heparin compared with aspirin for the treatment of acute ischaemic stroke in Asian patients with large artery occlusive disease: a randomised study","volume":"6","author":"Wong","year":"2007","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.neurol.2012.01.587_bib0285","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/j.1747-4949.2006.00062.x","article-title":"The challenge of acute-stroke management: does telemedicine offer a solution?","volume":"1","author":"Wu","year":"2006","journal-title":"Int J Stroke"}],"container-title":["Revue Neurologique"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S003537871200762X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S003537871200762X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,22]],"date-time":"2018-11-22T23:58:17Z","timestamp":1542931097000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S003537871200762X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6]]},"references-count":56,"journal-issue":{"issue":"6-7","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["S003537871200762X"],"URL":"https:\/\/doi.org\/10.1016\/j.neurol.2012.01.587","relation":{},"ISSN":["0035-3787"],"issn-type":[{"value":"0035-3787","type":"print"}],"subject":[],"published":{"date-parts":[[2012,6]]}}}